- Title
- Better therapy requires better response evaluation: Paving the way for minimal residual disease testing for every myeloma patient
- Creators
- Ola Landgren - Memorial Sloan Kettering Cancer CenterRoger G. Owen - St James's University HospitalCarl Ola Landgren - Miller School of Medicine
- Publication Details
- Cytometry. Part B, Clinical cytometry, Vol.90(1), pp.14-20
- Publisher
- Blackwell Publishing Ltd
- Edition
- How to cite this article: Landgren O. and Owen R. G. Better Therapy Requires Better Response Evaluation: Paving the Way for Minimal Residual Disease Testing for Every Myeloma Patient. Cytometry Part B 2016; 90B: 14-20.
- Number of pages
- 7
- Academic Unit
- Miller School of Medicine; UMMG Department of Medicine
- Language
- English
- Resource Type
- Journal article
- PMID
- 26147584
- Record Identifier
- 991031714023502976
Journal article
Better therapy requires better response evaluation: Paving the way for minimal residual disease testing for every myeloma patient
Cytometry. Part B, Clinical cytometry, Vol.90(1), pp.14-20
How to cite this article: Landgren O. and Owen R. G. Better Therapy Requires Better Response Evaluation: Paving the Way for Minimal Residual Disease Testing for Every Myeloma Patient. Cytometry Part B 2016; 90B: 14-20.
2016-01
PMID: 26147584
Metrics
1 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.130 Lymphomas
- 1.130.617 Multiple Myeloma
- Web Of Science research areas
- Medical Laboratory Technology
- Pathology
- ESI research areas
- Molecular Biology & Genetics
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites